# Progress Note 05 — Annual Wellness Visit, Subsequent

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Voltaire (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN002-SYN
- Date: 2026-04-28
- Fictional facility: St. Posthumous Health Center
- Fictional author: Honorine Delacroix-Mensah, MD
- Calendar frame: modern shifted

- Visit type: Annual Wellness Visit, Subsequent
- Services: HCPCS G0439 (subsequent annual wellness visit) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Subsequent annual wellness visit, a week after the bladder cancer diagnosis. **S**

## History of present illness

Voltaire returns for his subsequent annual wellness visit, six days after he learned that the bladder tumor is a muscle-invasive squamous cell carcinoma and chose weekly radiotherapy. The planning scan was done yesterday and the first treatment is tomorrow. His fever settled within two days of starting cefpodoxime, and he finished the seven-day course two days ago; the culture grew Escherichia coli sensitive to it. He has voided without a catheter for six days, getting up twice at night. He takes acetaminophen three times a day and has used two half tablets of oxycodone in six days, for bladder spasm in the evening; he keeps them in a locked box. He completed the health risk assessment beforehand. He has had no falls. He has cut his coffee to three cups a day and sleeps about five hours without the sleep aid. He is still at work on his play. **S**

| Element | Detail |
|---|---|
| Visit | Subsequent annual wellness visit, age 83 |
| Active conditions | Muscle-invasive squamous cell carcinoma of the bladder before radiotherapy; chronic retention, voiding; enlarged prostate; chronic constipation |
| Medicines | Tamsulosin, polyethylene glycol, senna, acetaminophen, oxycodone 2.5 mg as needed (two doses in six days), naloxone; cefpodoxime course completed two days ago |
| Safety events | No falls; one sick visit for the catheter infection; no hospital admission |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Fair; "better than my physicians expected, worse than I would like" |
| Psychosocial | Many visitors and friends; a live-in assistant; no money worries; low mood on some days since the diagnosis, without hopelessness |
| Behavioral | Never smoker; one glass of wine with dinner (AUDIT-C 2); coffee down to three cups a day; walks indoors and short distances outside |
| Activities of daily living | Independent in bathing, dressing, eating, toileting, and transfers |
| Instrumental activities of daily living | Manages his own medicines and correspondence; needs help with shopping, travel, and housework |
| Home safety | Smoke detectors working; night light on the way to the toilet added this week; no loose rugs |
| Hearing and vision | Hears well in conversation; reading glasses; eye examination last year |
| Bladder and bowel | Voids every two to three hours by day and twice at night; bowels open every one to two days on polyethylene glycol and senna |
| Memory | No concerns; still writing and directing rehearsals |
| Nutrition | Small appetite; weight 53.5 kg, down 0.7 kg in three weeks |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tires easily; weight down 0.7 kg; no fever for six days |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No nosebleeds since the episode in late winter |
| Cardiovascular | Negative | No chest pain or palpitations; no dizziness on standing |
| Respiratory | Negative | No cough, blood in the sputum, or breathlessness |
| Gastrointestinal | Negative | Bowels regular on the current regimen; no blood or pain |
| Genitourinary | Positive | Frequency and nocturia twice; urine pale pink at times; occasional evening bladder spasm |
| Musculoskeletal | Negative | No bone pain or falls |
| Integumentary | Negative | No rash; smallpox scars only |
| Neurological | Negative | No weakness, numbness, or memory change |
| Psychiatric | Positive | Low on some days since the diagnosis; PHQ-2 score 1; sleeps about five hours |

11 systems reviewed. **S**

## Current medications

- Tamsulosin 0.4 mg oral capsule, one capsule at bedtime **S**
- Polyethylene glycol 3350, 17 g in a glass of water once daily **S**
- Acetaminophen 500 mg oral tablet, two tablets by mouth three times daily (3 g a day) **S**
- Oxycodone 5 mg oral tablet, one half tablet (2.5 mg) by mouth every 6 hours if needed for bladder pain not relieved by acetaminophen, no more than three doses a day; 15 tablets dispensed **S**
- Sennosides 8.6 mg oral tablet, two tablets at bedtime while taking oxycodone **S**
- Naloxone 4 mg nasal spray, one spray in one nostril for suspected opioid overdose; call 911; may repeat in 2 to 3 minutes in the other nostril **S**

## Allergies

- No known allergy **S**

## Objective

BP 126/70 mmHg; pulse 78 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 96% on room air; weight 53.5 kg; BMI 18.5 kg/m². All vital signs are synthetic.

PHQ-2: 1; Mini-Cog: 4. All results are synthetic.

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Thin (BMI 18.5), alert, and quick; blood pressure 126/70 mmHg seated and 120/68 mmHg standing |
| Eyes | Near vision 20/40 with reading glasses |
| Ears | Whispered-voice test passed on both sides |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Clear |
| Abdomen | Soft; mild suprapubic tenderness; bladder not palpable |
| Musculoskeletal | Timed Up and Go 13 seconds with his stick; rises from a chair using his arms |
| Neurological | Oriented; Mini-Cog 4 of 5 (recall 2 of 3, clock normal) |
| Psychiatric | Wry and engaged; mood "steady, mostly"; no hopelessness |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Subsequent annual wellness visit completed**. Health risk assessment reviewed and the personalized prevention plan updated for a frail man of 83 starting cancer treatment: the plan now favors vaccines, falls prevention, nutrition, and planning for future care over cancer screening. PHQ-2, Mini-Cog, and alcohol screens are negative. **S**
   - Next annual wellness visit in one year.
2. **Catheter-associated urinary tract infection** (T83.511A). Resolved: afebrile for six days, seven-day course completed, voiding without a catheter; Escherichia coli sensitive to cefpodoxime. **S**
   - No further antibiotics.
3. **Squamous cell carcinoma of the bladder** (C67.4). Radiotherapy starts tomorrow; pain controlled with acetaminophen and two doses of oxycodone in six days, without sedation. **S**
   - Continue the pain plan; review in a week as planned.
4. **Fall risk**. Moderate: Timed Up and Go 13 seconds, uses a stick, takes tamsulosin and an as-needed opioid, and gets up at night, though he has not fallen. **S**
   - Night light and a urinal by the bed.
   - Physical therapy for strength and balance at home.
   - Stand slowly after tamsulosin.
5. **Low body weight**. BMI 18.5 with a 0.7 kg loss in three weeks; appetite small. **S**
   - Small frequent meals and an oral nutritional supplement twice a day.
   - Weight at every visit.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Influenza vaccine | Up to date | High-dose vaccine given in the autumn; next due next autumn |
| COVID-19 vaccine | Up to date | Current-season dose received at his pharmacy in the autumn |
| Pneumococcal vaccine | Up to date | PCV20 given; no further doses needed |
| RSV vaccine | Up to date | Single dose given; no repeat recommended |
| Recombinant zoster vaccine | Up to date | Two-dose series completed |
| Tetanus booster | Up to date | Tdap seven years ago; next due in three years |
| Depression screening | Completed today | PHQ-2 score 1; the palliative care team will also follow his mood |
| Alcohol misuse screening | Completed today | AUDIT-C 2; advised no alcohol on days he takes oxycodone |
| Cognitive assessment | Completed today | Mini-Cog 4 of 5 |
| Falls prevention | Referred | Home physical therapy for strength and balance; night light and urinal |
| Nutrition | Completed today | Oral supplement twice a day; weight at each visit |
| Medication review | Completed today | Diphenhydramine and phosphate enemas stopped at intake; no other high-risk medicines; one prescriber for the opioid |
| Colorectal cancer screening | Not indicated | Age 83 with a new cancer; after discussion he declines further screening |
| Prostate cancer screening | Not indicated | USPSTF recommends against PSA screening from 70; his PSA at intake was diagnostic, and no biopsy is planned |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never smoker; past the age range for aneurysm screening; chest CT clear at intake |
| Hearing and vision | Up to date | Whispered-voice test passed; eye examination last year |

## Advance care planning

Voluntary advance care planning discussion of about 25 minutes, with his consent, prompted by the cancer diagnosis. He names a long-time younger colleague as his health care agent and signed the state directive form today. He wants treatment that keeps him at home and able to write, including radiotherapy and treatment of infections, and a short hospital stay for a reversible problem such as bleeding or blocked urine. He would not want resuscitation, a breathing machine, or major surgery, and he wants comfort-focused care at home if the cancer progresses. A portable medical order for life-sustaining treatment was completed with these choices (do not attempt resuscitation; selective treatment). He wants frank information and asked that his medicines for pain and sleep be kept simple and prescribed by one clinician. **S**

## Guideline basis

- American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023), American Geriatrics Society
- Prostate Cancer: Screening (2018), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, urologic cancer and benign prostatic hyperplasia monographs (2026), Aether Forge
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention
- Falls Prevention in Community-Dwelling Older Adults: Interventions (2024), U.S. Preventive Services Task Force
- Colorectal Cancer: Screening (2021), U.S. Preventive Services Task Force
- Abdominal Aortic Aneurysm: Screening (2019), U.S. Preventive Services Task Force
- Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018), U.S. Preventive Services Task Force

## Follow-up

- Radiotherapy starts tomorrow. Chronic-care review in eight days as planned, with blood tests and a bladder scan. Home physical therapy this week. Next annual wellness visit in one year. **S**
- Next scheduled visit 2026-05-06: two-week review during weekly radiotherapy: symptoms, kidney function, voiding, and opioid safety. **S**
